Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

HIFEM (Emsella) to restore pelvic floor strength after a first vaginal birth

Official title: Effectiveness of HIFEM (High Intensity Focused Electro-Magnetic Technology) for Improving Pelvic Floor Muscle Tone in Postpartum Women: Study Protocol.

Run by Institut Investigacio Sanitaria Pere Virgili · NCT07528560 · Data updated 2026-11-12

This trial tests whether HIFEM (Emsella) treatments can help strengthen pelvic floor muscles in first-time mothers after a vaginal birth who do not have symptoms.

More Pelvic Floor Dysfunction trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorInstitut Investigacio Sanitaria Pere Virgili
Academic / other
Locations1 site (Tarragona, TARRAGONA)
StatusRecruiting
StartedApril 2026
Main results expectedJuly 1, 2026
Study endsDecember 2026
Registry record updatedApril 14, 2026
Trial IDNCT07528560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are first-time mothers who had a single-term vaginal delivery, are 6–12 weeks postpartum, currently have no pelvic floor symptoms, and have no contraindicated implants or serious medical conditions.

Probably not a fit

Women who already have pelvic floor symptoms, major pelvic trauma, are pregnant or menstruating, or who have implanted electronic or metallic devices or other exclusionary health conditions are unlikely to benefit from this preventive intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a non-randomized community interventional trial comparing primiparous women who receive BTL Emsella HIFEM treatment with those who follow natural recovery after a term vaginal delivery. Eligible participants are asymptomatic, singleton, full-term mothers enrolled between 6 and 12 weeks postpartum. Pelvic floor muscle strength and structure will be measured at baseline and follow-up using clinical measures and imaging (for example, transperineal ultrasound). The trial aims to determine whether adding HIFEM leads to greater recovery of pelvic floor function than natural recovery alone.

Why it matters

Potential benefit: If successful, the treatment could restore or preserve pelvic floor strength after childbirth and lower the future risk of incontinence, prolapse, or sexual dysfunction.

How similar studies have gone: HIFEM/Emsella received FDA clearance in 2018 for urinary incontinence and prior studies have shown improvements in pelvic floor strength and incontinence symptoms, but preventive use in asymptomatic postpartum women is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primiparous women
* Vaginal delivery.
* Single-fetus pregnancy / Singleton pregnancy.
* Full-term pregnancy (\> 37 weeks of gestation).
* Asymptomatic: No symptoms associated with pelvic floor muscle weakening, such as any type of incontinence or presence of prolapse.
* Post-quarantine period: Between 6 and 12 weeks postpartum

Exclusion Criteria:

* Implanted devices: Such as pacemakers, defibrillators, or neurostimulators.
* Electronic implants.
* Drug delivery pumps (e.g., insulin pumps or medication infusion pumps).
* Metallic implants.
* Intrauterine devices (IUDs) containing any type of metal.
* Application over the growth plate area.
* Severe or life-threatening disorders.
* Pulmonary insufficiency.
* Cardiac disorders / Heart conditions.
* Decompensated hemorrhagic conditions.
* Decompensated blood coagulation disorders.
* Malignant tumors / Malignancy.
* Fever.
* Epilepsy.
* Menstruation
* Pregnant

Where it's running

  • Centro Procrear
    Tarragona, Tarragona, Spain
    Recruiting

Study contacts

  • Principal investigator: Lys Garcia Vilaplana, Midwife. Phd Student — Universitat Rovira I Virgili. Procrear Medical Center
  • Study coordinator: LYS GARCIA VILAPLANA, Lead Researcher
  • Email: lys@procrear.es
  • Phone: +34619357158

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.